Joseph P. Mizgerd, ScD, professor of medicine, has received a seven year, $5.9 million “Outstanding Investigator Award” from the NHLBI at the NIH.
Joanne Murabito, MD, ScM, became Co-PI of the Framingham Heart Study on Jan. 1. She joins Dr. Vasan Ramachandran’s (FHS Director and PI) team along with Dr. Martin Larson (also Co-PI) at FHS.
Analyses of blood samples could add to the predictive value of traditional CVD risk factors.
Researchers identify genes whose expression accurately predicts patient survival.
Scientists are creating an induced pluripotent stem cell-based research library that opens the door to sickle cell disease research and therapy development.
Scott Hayes, PhD, found that older adults with good cardiac fitness may be keeping their brains in good shape.
New findings that appear in the journal Brain, show promise for detecting the influence of concussion on neurodegeneration.
Researchers have developed several performance measures for patients taking warfarin that may save lives and money.
Experts, including BUSM’s Elizabeth Pearce, have released new international guidelines for thyroid disease, which affects more than 300,000 pregnant women each year.
According to a study published online in the Journal of Substance Abuse Treatment, individuals with opioid use disorder who are treated with buprenorphine are more likely to disengage from treatment programs if they are black or Hispanic, unemployed or have hepatitis C.